We are monitoring the impact of COVID-19 & Recession alarm on Europe Biopharmaceuticals Market Get in touch with us for detailed analysis Know More

Know More

Share on

Europe Biopharmaceuticals Market Research Report – Segmented By Product Type, Therapeutic Type & Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe) - Industry Analysis, Size, Share, Growth, Trends and Forecast (2022 to 2027)

Published: January, 2022
ID: 583
Pages: 145

Europe Biopharmaceuticals Market Size (2022 to 2027)

The size of the European Biopharmaceuticals Market is projected at USD 48.19 billion in 2022 and estimated to be growing at a CAGR of 8.89%, to reach USD 73.78 billion by 2027. Europe is the second-largest market for Biopharmaceuticals globally. 

Europe is the second-largest Biopharmaceuticals market in the world. Increasing population and chronic diseases are propelling market growth. The adoption & accessibility, availability of Biopharmaceuticals for the treatment & diagnosis of diseases, awareness related to medicine raised the Europe Market. Western Europe contains more than 33% of manufacturing facilities worldwide. Biopharma products have high efficiency with safety than other products. Rising support from the government favors the growth rate of the European Biopharmaceuticals market during the forecast period.

The development of Biopharmaceuticals products is being undertaken by an increasing number of competitors in the pharmaceutical industry. Market players are more focusing on expanding the biologics pipeline, relying on the fact that the commercialization of Biopharmaceuticals will reduce the usage of traditional small molecular drugs. Pharmaceutical industries mainly rely on Biopharmaceuticals for profits and innovation.

Advancement in biomedical science holds vast potential for the growth of the Biopharmaceuticals market. The ability of these drugs to treat chronic diseases that were earlier untreatable is increasing its demand enormously and also increases the profit margin for manufacturers.

Biopharmaceuticals drugs need to be stored in cold storage, limiting their transport to rural areas and hence hindering the growth of the market.

This research report on the European Biopharmaceuticals Market has been segmented and sub-segmented into the following categories:

By Product Type: 

  • Monoclonal Antibodies (mAb)
  • Erythropoietin
  • Biotech Vaccines
  • Recombinant Human (RH) Insulin
  • Granulocyte Colony-stimulating Factor (G-CSF)
  • Interferon
  • Human Growth Hormones (HGH)

By Therapeutic Type: 

  • Neurology
  • Infectious Diseases
  • Diabetes
  • Oncology
  • Cardiovascular
  • Other Therapeutic Areas

By Country: 

  • UK
  • France
  • Spain
  • Germany
  • Italy
  • Russia
  • Sweden
  • Denmark
  • Switzerland
  • Netherlands
  • Turkey
  • Czech Republic
  • Rest of Europe

Regionally, Europe follows North America as the leading majority of the market share in the global market.

The German biopharmaceuticals market was the market leader in the European market, and this market is expected to have promising growth in the near future as well. The factors like development of Biopharmaceuticals products by competitors, commercialization of Biopharmaceuticals sector, and advancement in biomedical are responsible for the growth of the Biopharmaceuticals market.

The UK biopharmaceuticals market is expected to perform well between 2020 to 2025, and the French Biopharmaceuticals Market is expected to grow at a faster rate due to the accelerating focus on research and related investment. 

The Spanish biopharmaceuticals market performs much similar to France in leading the shares by increasing demand for advanced biomedical treatment. Enhancing awareness of Biopharmaceuticals products and investment by the government is additionally prompting the market to grow.

The Italian Biopharmaceuticals Market is expected to have a moderate growth rate during the forecast period and hold a decent market size by the end of 2025 as the government and private companies are pouring huge investments.

Notable companies leading the European Biopharmaceuticals market are Merck & Co., Inc., F. Hoffmann-La Roche AG, Eli Lilly and Company, Inc., Sanofi, Amgen Inc., AbbVie Inc., Biogen Idec, Bayer AG, Johnson & Johnson Services, Pfizer, Inc. and Novartis AG.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 New Developments                               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 By Product Type                       

                                5.1.1 Monoclonal Antibodies (mAb)       

                                5.1.2 Erythropoietin       

                                5.1.3 Biotech Vaccines  

                                5.1.4 Recombinant Human (RH) Insulin 

                                5.1.5 Granulocyte colony-stimulating factor (G-CSF)       

                                5.1.6 Interferon               

                                5.1.7 Human growth hormones (HGH)  

                5.2 By Therapeutic Type                               

                                5.2.1 Neurology               

                                5.2.2 Infectious diseases              

                                5.2.3 Diabetes  

                                5.2.4 Oncology 

                                5.2.5 Cardiovascular       

                                5.2.6 Other Therapeutic Areas  

6. Geographical Analysis                                              

                                6.1 Introduction               

                                6.2 U.K 

                                6.3 Spain             

                                6.4 Germany     

                                6.5 Italy               

                                6.6 France          

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Merck & Co.                               

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Strategic Evaluation and Operations            

                                8.1.4 Financial analysis  

                                8.1.5 Legal issues             

                                8.1.6 Recent Developments       

                                8.1.7 SWOT analysis       

                                8.1.8 Analyst View          

                8.2 F. Hoffmann-La Roche AG                    

                8.3 Eli Lilly and Company                              

                8.4 Sanofi                           

                8.5 Amgen Inc.                 

                8.6 AbbVie Inc.                 

                8.7 Biogen Idec                

                8.8 Bayer AG                     

                8.9 Johnson & Johnson Services                               

                8.10 Pfizer                          

                8.11 Novartis AG                             

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Expert Opinions                                        

                10.1 Market Outlook                     

                10.2 Investment Opportunities                 

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  1. Europe Biopharmaceuticals Market By Region, From 2022 - 2027 (USD Billion)
  2. Europe Biopharmaceuticals Market By Product Type, From 2022 - 2027 (USD Billion)
  3. Europe Monoclonal Antibodies (mAb) Market By Region, From 2022 - 2027 (USD Billion)
  4. Europe Erythropoietin Market By Region, From 2022 - 2027 (USD Billion)
  5. Europe Biotech Vaccines Market By Region, From 2022 - 2027 (USD Billion)
  6. Europe Recombinant Human (RH) Insulin Market By Region, From 2022 - 2027 (USD Billion)
  7. Europe Granulocyte colony-stimulating factor (G-CSF) Market By Region, From 2022 - 2027 (USD Billion)
  8. Europe Interferon Market By Region, From 2022 - 2027 (USD Billion)
  9. Europe Human growth hormones (HGH) Market By Region, From 2022 - 2027 (USD Billion)
  10. Europe Biopharmaceuticals market By Therapeutic Type, From 2022 - 2027 (USD Billion)
  11. Europe Neurology Market By Region, From 2022 - 2027 (USD Billion)
  12. Europe Infectious diseases Market By Region, From 2022 - 2027 (USD Billion)
  13. Europe Diabetes Market By Region, From 2022 - 2027 (USD Billion)
  14. Europe Oncology Market By Region, From 2022 - 2027 (USD Billion)
  15. Europe Cardiovascular Market By Region, From 2022 - 2027 (USD Billion)
  16. Europe Other Therapeutic Areas Market By Region, From 2022 - 2027 (USD Billion)
  17. U.K Biopharmaceuticals market By Product Type, From 2022 - 2027 (USD Billion)
  18. U.K Biopharmaceuticals market By Therapeutic Type, From 2022 - 2027 (USD Billion)
  19. Spain Biopharmaceuticals market By Product Type, From 2022 - 2027 (USD Billion)
  20. Spain Biopharmaceuticals market By Therapeutic Type, From 2022 - 2027 (USD Billion)
  21. Germany Biopharmaceuticals market By Product Type, From 2022 - 2027 (USD Billion)
  22. Germany Biopharmaceuticals market By Therapeutic Type, From 2022 - 2027 (USD Billion)
  23. Italy Biopharmaceuticals market By Product Type, From 2022 - 2027 (USD Billion)
  24. Italy Biopharmaceuticals market By Therapeutic Type, From 2022 - 2027 (USD Billion)
  25. France Biopharmaceuticals market By Product Type, From 2022 - 2027 (USD Billion)
  26. France Biopharmaceuticals market By Therapeutic Type, From 2022 - 2027 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

pdf
$

3335


pdf excel
$

3680


pdf excel powerbi
$

5520


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 3335

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample